Molecular diagnostic instrument

Getting your new molecular diagnostic (MDx) product to market quickly matters not only to you and your shareholders, but to the physicians and patients who need it.

A new technology company approached Plexus with a high investment hurdle - to launch and distribute a new MDx instrument for rapid bacterial detection, identification and antimicrobial susceptibility testing. This case study showcases how Plexus was able to minimize design and development delays, increase collaboration and help bring a new IVD technology to market.